Baofukang suppository combined with modified simiao decoction in treatment of colpitis mycotica and human papilloma virus infection

doi:10.3877/cma.j.issn.1673-5250.2019.05.017

Objective

To evaluate the clinical curative effect of baofukang suppository combined with modified simiao decoction on treatment of colpitis mycotica and human papilloma virus (HPV) infection.

Methods

A total of 120 cases of colpitis mycotica and 120 cases of HPV infection patients who were admitted in Chengde Central Hospital from March 2017 to March 2018 were chosen as research objects. With the random number table method, 120 colpitis mycotica patients were divided into observation group-1 (n=60) and control group-1 (n=60), respectively; while other 120 HPV infection patients were divided into observation group-2 (n=60) and control group-2 (n=60), respectively. The observation group-1 and observation group-2 were both treated with baofukang suppository combined with modified simiao decoction; while control group-1 and control group-2 were both only treated with baofukang suppository. The patients′ age, course of disease, and curative effect evaluation indexes including total effective rate and adverse reaction rates etc., were compared between observation group-1 and control group-1, also between observation group-2 and control group-2 by independent-samples t test and chi-square test. This study was consistent with World Medical Association Declaration of Helsinki revised in 2013. All patients and their family members were informed and signed the informed contents.

Results

①There were no significant differences between observation group-1 and control group-1 in patients′ age, course of disease, incidence rates of vulvar discomfort and algopareunia (P>0.05). The total effective rate of observation group-1 was 93.3%, which was significantly higher than that of 75.0% in control group-1; while the colpitis mycotica recurrence rate of observation group-1 was 5.0%, which was significantly lower than that of 23.3% in control group-1, and the differences were statistically significant (χ²=6.968, P=0.012; χ²=6.511, P=0.016). ② There were no significant differences between observation group-2 and control group-2 in patients′ age, course of disease, levels of serum tumor necrosis factor (TNF)-α and interferon-α before treatment, as well as the incidence rates of vulvar discomfort, lower abdominal pain, leucorrhea abnormality and contact bleeding (P>0.05). The total effective rate, HPV negative conversion rate, and levels of TNF-α and interferon-α after treatment in observation group-2 were 88.3%, 83.3%, (8.78±0.12) ng/L and (7.69±0.45) ng/L, which were significantly higher than those of 71.7%, 63.3%, (6.97±0.17) ng/L and (6.45±0.34) ng/L in control group-2, and the differences were statistically significant (χ²=6.097, P=0.041; χ²=7.156, P=0.012; t=6.214, P=0.026; t=5.861, P=0.048).

Conclusions

Baofukang suppository combined with modified simiao decoction would have better therapeutic effect than use baofukang suppository only in treatment of colpitis mycotica and HPV infection.

Key words: Candidiasis, vulvovaginal, Papillomavirus infections, Comparative effectiveness research, Modified simiao decoction, Baofukang suppository, Female

表1 观察组-1与对照组-1真菌性阴道炎患者一般临床资料及疗效评价指标比较

组别	例数	年龄(岁，±s)	病程(周，±s)	治疗总有效率[例数(%)]	外阴不适[例数(%)]	性交痛[例数(%)]	复发率[例数(%)]
观察组-1	60	35.2±1.2	4.0±1.3	56(93.3)	8(13.3)	3(5.0)	3(5.0)
对照组-1	60	33.6±0.9	4.2±1.6	45(75.0)	14(23.3)	4(6.7)	14(23.3)
检验值	?	t＝0.984	t＝1.026	χ²＝6.968	χ²＝2.004	χ²＝2.114	χ²＝6.511
P值	?	0.752	0.213	0.012	0.157	0.101	0.016

表1 观察组-1与对照组-1真菌性阴道炎患者一般临床资料及疗效评价指标比较

组别	例数	年龄(岁，±s)	病程(周，±s)	治疗总有效率[例数(%)]	外阴不适[例数(%)]	性交痛[例数(%)]	复发率[例数(%)]
观察组-1	60	35.2±1.2	4.0±1.3	56(93.3)	8(13.3)	3(5.0)	3(5.0)
对照组-1	60	33.6±0.9	4.2±1.6	45(75.0)	14(23.3)	4(6.7)	14(23.3)
检验值	?	t＝0.984	t＝1.026	χ²＝6.968	χ²＝2.004	χ²＝2.114	χ²＝6.511
P值	?	0.752	0.213	0.012	0.157	0.101	0.016

表2 观察组-2与对照组-2人乳头瘤病毒感染患者一般临床资料及疗效评价指标比较

组别	例数	年龄(岁，±s)	病程(周，±s)	TNF-α(ng/L，±s)		α-干扰素(ng/L，±s)
组别	例数	年龄(岁，±s)	病程(周，±s)	治疗前	治疗后	治疗前	治疗后
观察组-2	60	36.8±1.0	4.4±1.6	5.36±0.23	8.78±0.12	4.39±0.41	7.69±0.45
对照组-2	60	37.2±0.6	4.6±1.1	5.32±0.19	6.97±0.17	4.52±0.23	6.45±0.34
检验值	?	t＝1.216	t＝1.006	t＝4.993	t＝6.214	t＝4.625	t＝5.861
P值	?	0.737	0.352	0.221	0.026	0.186	0.048^a
组别	例数	治疗总有效率[例数(%)]	HPV转阴率[例数(%)]	不良反应[例数(%)]
组别	例数	治疗总有效率[例数(%)]	HPV转阴率[例数(%)]	外阴不适	小腹疼痛	白带异常	接触性出血
观察组-2	60	53(88.3)	50(83.3)	2(3.3)	2(3.3)	4(6.6)	3(5.0)
对照组-2	60	43(71.7)	38(63.3)	4(6.6)	4(6.6)	6(10.0)	3(5.0)
检验值	?	χ²＝6.097	χ²＝7.156	χ²＝1.689	χ²＝1.689	χ²＝1.265	χ²＝0.845
P值	?	0.041	0.012	0.132	0.132	0.178	1.000

表2 观察组-2与对照组-2人乳头瘤病毒感染患者一般临床资料及疗效评价指标比较

组别	例数	年龄(岁，±s)	病程(周，±s)	TNF-α(ng/L，±s)		α-干扰素(ng/L，±s)
组别	例数	年龄(岁，±s)	病程(周，±s)	治疗前	治疗后	治疗前	治疗后
观察组-2	60	36.8±1.0	4.4±1.6	5.36±0.23	8.78±0.12	4.39±0.41	7.69±0.45
对照组-2	60	37.2±0.6	4.6±1.1	5.32±0.19	6.97±0.17	4.52±0.23	6.45±0.34
检验值	?	t＝1.216	t＝1.006	t＝4.993	t＝6.214	t＝4.625	t＝5.861
P值	?	0.737	0.352	0.221	0.026	0.186	0.048^a
组别	例数	治疗总有效率[例数(%)]	HPV转阴率[例数(%)]	不良反应[例数(%)]
组别	例数	治疗总有效率[例数(%)]	HPV转阴率[例数(%)]	外阴不适	小腹疼痛	白带异常	接触性出血
观察组-2	60	53(88.3)	50(83.3)	2(3.3)	2(3.3)	4(6.6)	3(5.0)
对照组-2	60	43(71.7)	38(63.3)	4(6.6)	4(6.6)	6(10.0)	3(5.0)
检验值	?	χ²＝6.097	χ²＝7.156	χ²＝1.689	χ²＝1.689	χ²＝1.265	χ²＝0.845
P值	?	0.041	0.012	0.132	0.132	0.178	1.000

[1]	Paavonen J, Brunham RC. Bacterial vaginosis and desquamative inflammatory colpomycosis[J]. N Engl J Med, 2018, 379(23): 2246-2254.
[2]	Hillier SL, Austin M, MacIo I, et al. Clinical practice and accuracy of colpomycosis diagnosis in community based settings[J]. Am J Obstet Gynecol, 2018, 219(6): 641.
[3]	Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States[J]. JAMA, 2007, 297(8): 813.
[4]	薛凤霞，王宝晨. 中国HPV感染面临的问题与挑战[J]. 国际生殖健康/计划生育杂志，2015, 34(6): 445-449.
[5]	何志晖，寇增强，徐爱强. HPV感染及其免疫预防[J]. 中华预防医学杂志，2018, 52(1): 106-112.
[6]	Burchell AN, Winer RL, de Sanjosé S, et al. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection[J]. Vaccine, 2006, 24(Suppl 3): S3/52-S3/61.
[7]	Stanley M. Pathology and epidemiology of HPV infection in females[J]. Gynecol Oncol, 2010, 117(2 Suppl): S5-S10.
[8]	Paladine HL, Desai UA.Colpomycosis: diagnosis and treatment[J]. Am Fam Physician, 2018, 97(5): 321-329.
[9]	赵鸿达，冯晓玲，赵颜，等. 苦参凝胶治疗宫颈HPV感染患者的随机对照临床研究[J]. 中国中药杂志，2016, 41(21): 4072-4075.
[10]	Bossens M, Jost M, Van Pachterbeke C, et al. Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: a phase 1 investigation[J]. Int J Clin Pharmacol Ther, 2018, 56(3): 134-141.
[11]	Lin J, Chen L, Qiu X, et al. Traditional Chinese medicine for human papillomavirus (HPV) infections: a systematic review[J]. Biosci Trends, 2017, 11(3): 267-273.
[12]	曹泽毅. 中华妇产科学[M]. 3版. 北京：人民卫生出版社，2005: 3287-3289.
[13]	乐杰. 妇产科学[M]. 7版. 北京：人民卫生出版社，2008: 223-226.
[14]	崔艳华，杨丹丹. 中药内服外洗治疗复发性霉菌性阴道炎疗效观察[J]. 实用中医药杂志，2017, 33(11): 1244-1245.
[15]	张彩宇. 清热化湿中药方剂辅助治疗阴道炎临床观察[J]. 新中医，2016, 48(4): 129-131.
[16]	冯玉琴，王森绍. 中药清热扶正法干预宫颈癌前病变高危型HPV感染的效果观察[J]. 北方药学，2018, 15(8): 64-65.

[1]	Minrong Ma, Cong Li, Qin Zhou. Current research status of treatment of cervical cancer[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 497-504.
[2]	Changsheng Lin, Jun Zhan, Xue Xiao. Genetic testing and precision molecular targeted therapy in diagnosis and treatment of epithelial ovarian caner[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 505-510.
[3]	Juan Gu, Qingqing Sun, Fangfang Hu, Yijuan Cao, Yujuan Qi. Clinical application of endometrial receptivity array to improve pregnancy outcomes in women with repeated embryo implantation failure[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 582-587.
[4]	Wenrong Dai, Lijuan Zhao, Zhihui Li. Research progress of influence of extracellular vesicles on embryo implantation[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 616-620.
[5]	Dongjie Zhou, Min Jiang, Hairui Fan, Lingling Gao, Xiang Kong, Dan Lu, Liping Wang. Current research progress on non-coding RNA in follicular development and maturation[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 387-393.
[6]	Huizhu Chen, Yingkun Guo, Xinrong Wang, Gang Ning, Xijian Chen. Current research status on the " dualistic model" of epithelial ovarian cancer and its molecular biology[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 394-402.
[7]	Chunying Han, Tingting Wang, Yanyan Li, Jinxia Piao. Current research status on predictors of lymphatic vascular invasion in patients with endometrial carcinoma[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 403-409.
[8]	Bo Mo, Pei Wang, Heng Wang, Zhijun He, Jun Liang, Zhinan Hao. Curative effect of laparoscopic radical gastrectomy and modified radical gastrectomy for early gastric cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 644-647.
[9]	Duojie Suolang, Hongqiao Gao, Dunzhu Basang, Sang Ren. Clinical analysis of different laparoscopic procedures in the treatment of hepatic cystic echinococcosis in Tibet[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 670-673.
[10]	Hao Tang, Ping Liang, Xiaojiang Xu, Kai Zeng, Pohui Wen. The clinical studies of laparoscopic right hemihepatectomy with caudate lobectomy under the guidanceof three-dimensional reconstruction for Bismuth type Ⅲahilar cholangiocarcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 688-692.
[11]	Yi Wang, Sizhe Xu, Zhangxia Ren. Effect of endoscopic unilateral thyroid lobectomy via thoracic breast approach and open surgery on postoperative recovery in patients with differentiated thyroid cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 542-545.
[12]	Weiqiang Fan, Shibu Lin, Chuanwei Sun, Qifeng Song, Wang Li, Yu Fu, Ai Chen. Clinical comparative analysis of Bismuth-Corlette Ⅲ and Ⅳ laparoscopic surgery for hilar cholangiocarcinoma with different resection scopes[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 423-426.
[13]	Jie Zhang, Yuan Lyu, Liang Sun, Hui Su, Hui Xie, Qiang Yuan, Xin Wang, Junfeng Du, Peng Jin, Gang Chen. Clinical analysis of combined laparoscope-gastroscopy for the treatment of difficult gastric stromal tumors[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 284-286.
[14]	LangBiao Liu, Lei Niu, Jun Cai. Application of λ esophagojejunostomy in total laparoscopic gastrectomy[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 287-291.
[15]	Jixin Chai, Xue Zhang, Shizhi He, Yantao Qi, Jingjing Wang, Yazhou Ao, Yong Chen. Application of different puncture methods to cytological examination of thyroid nodule[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 315-318.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export